Polish Radio reports the warehouse chain will carry Novo Nordisk's two popular GLP-1 drugs, adding another place for buyers to fill prescriptions.
Recap by typeshit. Full story at www.polskieradio.pl.
The GLP-1 Bridge pilot runs through 2027 and covers approved pills and shots for eligible Part D and Advantage enrollees, with no deductible.
Le Figaro reports the tablet arrives in early November. Unlike the Wegovy injection, it won't be covered by France's public reimbursement system.
A TV segment airing on WSIL and KFVS looks at the weight loss drug trend and what coverage people might be able to get through their insurance today.
Monthly units climbed from 114,000 in February to 434,000 in September, and sales value rose from ₹48 cr to ₹113 cr as doctors report wider access.
A short general post notes the investigational triple agonist has shown strong trial results but can cause side effects. Thin on detail.
New real-world data compares two paths for cardiovascular outcomes: stepping up the semaglutide dose or moving patients over to tirzepatide.
Loading…